Metastatic Colorectal Cancers Terminated Phase 1 Trials for Navicixizumab (DB12634)

Also known as: Colorectal cancer metastatic / Metastatic Colorectal Cancer

IndicationStatusPhase
DBCOND0063579 (Metastatic Colorectal Cancers)Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03035253A Study of OMP-305B83 in Subjects With Metastatic Colorectal CancerTreatment